Flow cytometry‐guided ex vivo drug sensitivity testing informs venetoclax‐based therapy in acute undifferentiated leukaemia
The data that support the findings of this study are available from the corresponding author upon reasonable request. Data S1. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Authors
- Dai‐Hong Liu (ORCID: https://orcid.org/0000-0003-3334-9113)
- Jun Yong (ORCID: https://orcid.org/0000-0002-3770-2108)
- Weifeng Lai
- Yufang Li (ORCID: https://orcid.org/0000-0002-7428-9615)
- Wen Zhao (ORCID: https://orcid.org/0000-0003-0910-9427)
- Yizhi Wang (ORCID: https://orcid.org/0009-0008-1449-8424)
- Yi-Xiang Wang (ORCID: https://orcid.org/0000-0002-4021-4228)
- Chunji Gao
- X Gao
- Yalei Hu
- Lei Xu
Institutions
- Chinese PLA General Hospital (CN)
- BOE Technology Group (China) (CN)
- PLA Academy of Military Science (CN)
Publication Details
- Journal
- British Journal of Haematology
- Published
- 2026-04-17
- DOI
- https://doi.org/10.1111/bjh.70499
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Beijing Municipal Science and Technology Commission
- Beijing Nova Program
- National Key Research and Development Program of China